Telomir Pharmaceuticals, Inc. (TELO) Operating cash flow 2022–2025
Telomir Pharmaceuticals, Inc. (TELO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.7MFY2025 · since FY2022: -$468,661 → -$3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.7M | +27.3% |
| FY2024 | -$5.1M | -31.4% |
| FY2023 | -$3.9M | -723.6% |
| FY2022 | -$468,661 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TELO financial trends
TELO RevenueTELO Net incomeTELO Net marginTELO Gross profitTELO Gross marginTELO Operating incomeTELO Operating marginTELO Free cash flowTELO Capital expendituresTELO Return on equityTELO Stock buybacksTELO Dividends paidTELO Total assetsTELO Total liabilitiesTELO Shareholders’ equityTELO overview →